To determine whether CCL17 inhibition ameliorates Ang II–induced pathological cardiac hypertrophy, WT mice were simultaneously treated with anti-CCL17 antibodies or isotype IgG after a 4-wk saline or Ang II infusion (Fig. 5 A). This evidence concerns the gene CCL17 and cardiac hypertrophy.